The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
Abstract
&NA; Tumor metastasis is the primary factor causing death of cancer patients and it is a study emphasis in cancer treatment to suppress tumor metastasis by inhibiting glycolysis, which is the main way of energy supply for cell mobility in tumor. In the present study, we aimed to explore the effect of quercetin, a bioactive flavonoid, on tumor metastasis and cell glycolysis and its related functionary mechanism in breast cancer progression. Firstly, trans‐well invasion assay and wound healing assay indicated that quercetin effectively suppressed cell mobility. The corresponding western blot revealed that quercetin treatment down‐regulated the expression of cell migration marker proteins, such as matrix metalloproteinase 2 (MMP‐2), MMP‐9 and vascular endothelial growth factor (VEGF). The further experiments exhibited that quercetin successfully blocked cell glycolysis by inhibiting the level of glucose uptake and the production of lactic acid, and also decreased the level of glycolysis‐related proteins Pyruvate kinase M2 (PKM2), Glucose transporter1(GLUT1) and Lactate dehydrogenase A (LDHA). The above results revealed that quercetin might inhibit glycolysis to limit the migration of tumor cells by reducing the acidity of the tumor microenvironment. Moreover, our further investigation showed that quercetin induced obvious autophagy via inactivating the Akt‐mTOR pathway. At the same time, the application of autophagy inhibitor 3‐MA and Akt‐mTOR pathway inducer IGF‐1 further demonstrated that quercetin exerted inhibiting effect on cell mobility and glycolysis through Akt‐mTOR pathway mediated autophagy induction. At last, the in vivo experiments also showed that quercetin treatment could suppress tumor growth and metastasis, inhibit glycolysis and induce autophagy through the inhibition of p‐AKT/AKT. Taken together, we firstly revealed that quercetin suppressed the progression of breast cancer by inhibiting cell mobility and glycolysis through Akt‐mTOR pathway mediated autophagy induction and may provide a potential therapeutic target for breast cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Yang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3941 · Cited by 70
RetractedYang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5206 · Cited by 60
RetractedGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,513
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
Oncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
A Mitochondrial Switch Promotes Tumor Metastasis
Porporato, P. E., Payen, V. L., Pérez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.043 · Cited by 571
Global cancer control: responding to the growing burden, rising costs and inequalities in access
Prager, G. W., Braga, S., Bystricky, B., Qvortrup, C., Criscitiello, C., Esin, E., Sonke, G. S., Martínez, G., Frenel, J.-S., Karamouzis, M., et al. (2018) · ESMO Open · doi:10.1136/esmoopen-2017-000285 · Cited by 310
Jiao, L., Zhang, H.-L., Li, D.-D., Yang, K.-L., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R.-Y., Ravichandran, S., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1381804 · Cited by 264
Li, L., Kang, L., Zhao, W., Feng, Y., Liu, W., Wang, T., Mai, H., Huang, J., Chen, S., Liang, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.034 · Cited by 207
Cited by
The anti-cancer effect of quercetin: molecular implications in cancer metabolism
Reyes-Farias, M., & Carrasco-Pozo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133177 · Cited by 689
“Quercetin (30 μM) also has been shown to decrease LDH-A protein levels in breast cancer, MDA-MB-231, and MCF-7 cells [64].”
BackgroundInfluentialTherapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
Salehi, B., Machin, L., Monzote, L., Sharifi-Rad, J., Ezzat, S. M., Salem, M. A., Merghany, R. M., El Mahdy, N. M., Kılıç, C. S., Sytar, O., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01818 · Cited by 707
Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Tang, S.-M., Deng, X.-T., Zhou, J., Li, Q.-P., Ge, X.-X., & Miao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109604 · Cited by 654
A review on anti-cancer properties of Quercetin in breast cancer
Ezzati, M., Yousefi, B., Velaei, K., & Safa, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117463 · Cited by 356
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Garcia-Oliveira, P., Otero, P., Pereira, A. G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., & Prieto, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14020157 · Cited by 303
Metadata
- Authors
- Jia, L., Huang, S., Yin, X., Zan, Y., Guo, Y., & Han, L.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 208
- Pages
- 123-130
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2884744510
- Cited by
- 304
- References
- 27
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. https://app.cochat.ai/papers/10.1016/j.lfs.2018.07.027
- The paper
- Jia, L., Huang, S., Yin, X., Zan, Y., Guo, Y., & Han, L. (2018). Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sciences. https://doi.org/10.1016/j.lfs.2018.07.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.